Clinical Trial Update: Comparison Between Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients With Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial comparing atorvastatin and rosuvastatin for reduction of inflammatory biomarkers in acute coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Rosuvastatin (rosuvastatin)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Rawalpindi Medical College | Conditions: Mi Q Wave | Phase 4 | Status: COMPLETED